Related Experiment Videos
Lipoprotein(a) is a potential coronary risk factor.
A Fujino1, T Watanabe, H Kunii
1Department of Internal Medicine, Yonezawa City Hospital, Yamagata, Japan.
Japanese Circulation Journal
|January 29, 2000
Summary
Lipoprotein(a) (Lp(a)) is a significant coronary risk factor. Lowering serum Lp(a) levels is crucial for managing ischemic heart disease (IHD) patients, as it
Area of Science:
- Cardiology
- Clinical Biochemistry
Background:
- Lipoprotein(a) (Lp(a)) is an emerging risk factor for coronary artery disease.
- Quantitative assessment of Lp(a) in relation to other risk factors in patients undergoing coronary angiography is limited.
Purpose of the Study:
- To quantitatively assess the relationship between serum Lp(a) levels and other coronary risk factors.
- To determine the association of these risk factors with the number of coronary vessels involved in 1,006 patients.
Main Methods:
- Seventeen coronary risk factors were quantified in 1,006 patients undergoing coronary cineangiography.
- Multiple regression analysis was employed to evaluate the relationship between risk factors and the number of affected coronary vessels.
Main Results:
- Age, Lp(a), impaired glucose tolerance, total cholesterol, and cerebrovascular accidents showed significant positive associations with coronary artery disease severity.
- High-density lipoprotein (HDL)-cholesterol and apolipoprotein A-I (apoA-I) levels were inversely correlated with disease severity.
- Lp(a) emerged as an independent predictor of coronary artery disease, with a beta weight of 0.174 (p<0.001).
Conclusions:
- Lipoprotein(a) (Lp(a)) is an independent, potential, and modifiable risk factor for coronary artery disease.
- Reducing serum Lp(a) levels is important for the clinical management of patients with ischemic heart disease (IHD).